Deal Library / Pharma BD Deal Intelligence

Multiple Deals

The Pharma Closeout tracks 5 deals, $6.4B in disclosed deal value, 4 with a post-close Outcome Score for Multiple.

Median Critic Score: 72  ·  Median Outcome Score: 42

Best outcome: Watson Pharmaceuticals Inc. / Schein Pharmaceutical Inc. (65)  ·  Weakest outcome: Concordia Healthcare Corp. / Amdipharm Mercury Limited (AMCo) (16)

All 5 deals

• Watson Pharmaceuticals Inc. / Schein Pharmaceutical Inc. — 2000 · $674M · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Novopharm Limited — 2000 · $600M · Largely worked — most objectives met.
• Cephalon, Inc. / Mepha AG — 2010 · $615M · Did not work — the deal failed to deliver.
• Concordia Healthcare Corp. / Amdipharm Mercury Limited (AMCo) — 2015 · $3.5B · Did not work — the deal failed to deliver.
• Takeda Pharmaceutical Company Ltd. / Nabla Bio, Inc. — 2025 · $1.0B

← Deal Library  ·  Interactive search  ·  How we score deals